High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer.

MLA

Bick, Ulrich, et al. “High-Risk Breast Cancer Surveillance with MRI: 10-Year Experience from the German Consortium for Hereditary Breast and Ovarian Cancer.” Breast Cancer Research and Treatment, vol. 175, no. 1, May 2019, pp. 217–28. EBSCOhost, https://doi.org/10.1007/s10549-019-05152-9.

APA

Bick, U., Engel, C., Krug, B., Heindel, W., Fallenberg, E. M., Rhiem, K., Maintz, D., Golatta, M., Speiser, D., Rjosk-Dendorfer, D., Lämmer-Skarke, I., Dietzel, F., Schäfer, K. W. F., Leinert, E., Weigel, S., Sauer, S., Pertschy, S., Hofmockel, T., Hagert-Winkler, A., … Schmutzler, R. K. (2019). High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer. Breast Cancer Research and Treatment, 175(1), 217–228. https://doi.org/10.1007/s10549-019-05152-9

Chicago

Bick, Ulrich, Christoph Engel, Barbara Krug, Walter Heindel, Eva M Fallenberg, Kerstin Rhiem, David Maintz, et al. 2019. “High-Risk Breast Cancer Surveillance with MRI: 10-Year Experience from the German Consortium for Hereditary Breast and Ovarian Cancer.” Breast Cancer Research and Treatment 175 (1): 217–28. doi:10.1007/s10549-019-05152-9.